Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies (Q57556550)

2

object named as

Joachim L. Schultze

0 references

author name string

Andreas Trojan

1

0 references

Mathias Witzens

3

0 references

Robert H. Vonderheide

4

0 references

John W. Donovan

6

0 references

John G. Gribben

https://scigraph.springernature.com/pub.10.1038/76243

7

0 references

language of work or name

English

0 references

publication date

June 2000

0 references

published in

Nature Medicine

0 references

volume

6

0 references

issue

6

0 references

page(s)

667-672

0 references

exact match

0 references

cites work

Recognition of immunoglobulin idiotypes by thymus-derived lymphocytes

1 reference

Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules

21 January 2018

1 reference

Anti-tumour activity of idiotype-specific, MHC-restricted Th1 and Th2 clones in vitro and in vivo

21 January 2018

1 reference

DNA immunization induces protective immunity against B-cell lymphoma

21 January 2018

1 reference

B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells

21 January 2018

1 reference

MHC class II-restricted presentation of intracellular antigen

21 January 2018

1 reference

Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumors

21 January 2018

1 reference

Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors

21 January 2018

1 reference

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

21 January 2018

1 reference

B cells turn off virgin but not memory T cells

21 January 2018

1 reference

B cells directly tolerize CD8(+) T cells

21 January 2018

1 reference

SYFPEITHI: database for MHC ligands and peptide motifs

21 January 2018

1 reference

Recognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes

21 January 2018

1 reference

A kinetic basis for T cell receptor repertoire selection during an immune response

21 January 2018

1 reference

Two complementary methods for predicting peptides binding major histocompatibility complex molecules.

21 January 2018

1 reference

Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes

21 January 2018

1 reference

The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes

21 January 2018

1 reference

Peptide binding to MHC class I molecules: implications for antigenic peptide prediction

21 January 2018

1 reference

CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy

21 January 2018

1 reference

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

21 January 2018

1 reference

Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

21 January 2018

1 reference

21 January 2018

1 reference

Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative

21 January 2018

1 reference

Inducing autoimmune disease to treat cancer

21 January 2018

1 reference

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11.

21 January 2018

1 reference

DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma

21 January 2018

1 reference

7 January 2021

Resting small B cells present endogenous immunoglobulin variable-region determinants to idiotope-specific CD4(+) T cells in vivo

1 reference

7 January 2021

Immunogenicity and cross-reactivity with idiotypic IgA of VH CDR3 peptide in multiple myeloma

1 reference

7 January 2021

T cells recognize the VH complementarity-determining region 3 of the idiotypic protein of B cell non-Hodgkin's lymphoma

1 reference

7 January 2021

T-cell-epitope mapping of the idiotypic monoclonal IgG heavy and light chains in multiple myeloma

1 reference

7 January 2021

Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing

1 reference

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

7 January 2021